JK

Jayan Kanakkizhi Kandari

Director Managing Director DIN 03033225
DIN 03033225 First appointment May 2010 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since May 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Jayan Kanakkizhi Kandari

Data last updated:

Jayan Kanakkizhi Kandari was a Managing Director at Zoomex Therapeutics Private Limited (2010–2015). The company operates in Pharma.

DIN 03033225
Primary Designation Managing Director
Industry Pharma
First Appointment 06 May 2010

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zoomex Therapeutics Private Limited U24233KL2010PTC025969
Managing Director06 May 20102010₹12 Lakh (FY 2022)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Zoomex Therapeutics Private Limited
Premium access

Shareholding and investment profile for Jayan Kanakkizhi Kandari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jayan Kanakkizhi Kandari

Jayan Kanakkizhi Kandari was first appointed on 06 May 2010 as Managing Director at Zoomex Therapeutics Private Limited.

Jayan Kanakkizhi Kandari held 1 earlier board appointment: Zoomex Therapeutics Private Limited (Managing Director, 06 May 2010 to 11 Sep 2015).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available